bluebird bio Stock (NASDAQ: BLUE) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.68K / 7.41M |
Day Range | - - - |
52 Wk Range | 0.46 - 5.53 |
Market Cap | $91.53M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 27.18% |
Days to Cover | 5.35 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of bluebird bio (NASDAQ:BLUE) through any online brokerage.
Other companies in bluebird bio’s space includes: Renovaro (NASDAQ:RENB), Skye Bioscience (NASDAQ:SKYE), CytomX Therapeutics (NASDAQ:CTMX), Immuneering (NASDAQ:IMRX) and Armata Pharmaceuticals (AMEX:ARMP).
bluebird bio has a consensus price target of $4.73.
The stock price for bluebird bio (NASDAQ: BLUE) is $0.472 last updated September 23, 2024 at 4:44 AM EDT.
There are no upcoming dividends for bluebird bio.
bluebird bio’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for bluebird bio.
bluebird bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.